THE VOGEL GROUP

Lobbying for FORTRESS BIOTECH INC. · Biopharma venture studio that builds, funds, and manages a portfolio of drug-dev companies

Filing 2nd Quarter - Termination

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Florida

Representation ended

Apr 1, 2026

The registrant reported terminating its work for this client.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

Lobbying activity 1

Health Issues

Give kids a chance act H.R.1262; issues related to rare pediatric disease and priority review vouchers

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.